Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D02PKO
|
||||
| Former ID |
DNC004460
|
||||
| Drug Name |
3-(4-Methoxy-benzenesulfonyl)-cyclopentanethiol
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [525535] | ||
| Formula |
C12H16O3S2
|
||||
| Canonical SMILES |
COC1=CC=C(C=C1)S(=O)(=O)C2CCC(C2)S
|
||||
| InChI |
1S/C12H16O3S2/c1-15-9-2-5-11(6-3-9)17(13,14)12-7-4-10(16)8-12/h2-3,5-6,10,12,16H,4,7-8H2,1H3
|
||||
| InChIKey |
JDPMCWHMTGTQGU-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Collagenase 3 | Target Info | Inhibitor | [525535] | |
| NetPath Pathway | IL1 Signaling Pathway | ||||
| PANTHER Pathway | Alzheimer disease-presenilin pathway | ||||
| Plasminogen activating cascade | |||||
| Pathway Interaction Database | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.